Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →Dabur India reported consolidated revenue growth of 6.1% YoY for Q3 FY26, with domestic FMCG growing 6% on 3% volume growth.
✓ Verified against BSE filing
Dabur India reported consolidated revenue growth of 6.1% YoY for Q3 FY26, with domestic FMCG growing 6% on 3% volume growth. Operating profit rose 7.7% and PAT grew 10.1% (7.2% adjusted for one-time labor law provision). Growth was driven by strong HPC performance (hair oil +19.1%, toothpaste +10%), rural outperformance, and market share gains in hair oils (193 bps) and juices (650 bps). International business grew 11% in INR terms. Management expects high single-digit revenue growth in Q4 with EBITDA margin expansion, targeting a return to 20% operating margin. Key risks include volatile commodity prices (coconut oil softening) and competitive intensity in oral care.
डाबर इंडिया ने तीसरी तिमाही में पिछले साल की तुलना में कुल कमाई में 6.1% की बढ़ोतरी दर्ज की। घरेलू एफएमसीजी कारोबार में 6% की वृद्धि हुई, जिसमें 3% वृद्धि बिक्री की मात्रा में हुई। कंपनी का परिचालन लाभ 7.7% और शुद्ध लाभ 10.1% बढ़ा। मजबूत प्रदर्शन हेयर ऑयल (19.1% वृद्धि) और टूथपेस्ट (10% वृद्धि) से आया। ग्रामीण बाजारों में बेहतर प्रदर्शन रहा। अंतरराष्ट्रीय कारोबार में 11% वृद्धि हुई। कंपनी को चौथी तिमाही में अच्छी वृद्धि और मुनाफे में सुधार की उम्मीद है। मुख्य जोखिमों में नारियल तेल की कीमतों में उतार-चढ़ाव और ओरल केयर में प्रतिस्पर्धा शामिल है।
0 delivered, 0 close, 1 missed.
View Promises →Coconut oil price volatility
View Risks →Full transcript text is available on this route.
Read Transcript →Overall volume market share in hair oils reached an all-time high of 20%.
Gained 650 bps market share in the juices category.
Herbal segment grew 530 bps ahead of non-herbal in oral care.
Gained 131 bps market share in the air freshener category.
Management anticipates EBITDA margin expansion in Q4 compared to last year, despite Q4 being a lower margin quarter.
Targeting high single-digit to low double-digit revenue growth for FY27, with volume growth being the primary driver.
Management aims to return to 20% operating margin through cost savings and proactive price increases.
Management expects Q4 revenue growth to be high single-digit, in line with or slightly above Q3's 6.1%.
Management indicated margins will be better than top line, supported by cost savings of ~INR 60 crore in H1 and continued initiatives.
Capital allocation of INR 500 crore for minority/majority stakes in digital-first brands within existing categories (HPC, healthcare, foods).
Coconut oil prices have softened but remain volatile; further declines could impact revenue growth as price-driven growth subsides.
Competition in oral care, especially in modern trade, remains high; management noted abatement but not sustained.
Juice and glucose businesses are highly dependent on favorable summer weather; unfavorable season could hurt growth.
CFO highlighted a 1.25-1.5% gap between output and input GST rates, which could require price increases or cost renegotiations.
Nepal business declined 15% due to political disturbance; US tariffs impacted Badshah exports. Management noted these as unforeseen headwinds.
Mentioned in Q2 FY25, Q4 FY25
Beverage segment faces heightened competition from Campa Cola and others, with management expecting only low to mid-single-digit growth in FY26.
Mentioned in Q1 FY25, Q2 FY25
Currency depreciation in Egypt and Turkey caused a translation loss of INR 181 crore in H1, impacting reported international profitability.
Mentioned in Q1 FY25, Q2 FY25
Management expects the home care portfolio to grow from INR 700 crore to INR 1,000 crore in a two- to three-year time frame.
Mentioned in Q2 FY25, Q3 FY25
Urban consumption growth has moderated to ~5%, impacting categories like juices and healthcare supplements.
Management expects Q4 revenue growth to be high single-digit, in line with or slightly above Q3's 6.1%.
Coconut oil prices have softened but remain volatile; further declines could impact revenue growth as price-driven growth subsides.
View Risks →